| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| VANGUARD MIDCAP ETF | 124,062 | 124,062 |
| EQUITY FUNDS - SEE ATTACHMENT | 553,290 | 553,290 |
| OBI PHARMA INC - 195,000 SHS | 964,667 | 964,667 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FILING AND LICENSES FEES | 25 | 0 | 0 | 25 |
| OFFICE EXPENSES |
| Description | Amount |
|---|---|
| UNREALIZED GAIN ON INVESTMENTS | 198,879 |
| GRANTS PAYABLE CASH/ACCRUAL DIF. | 107,500 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOUNDATION MGMT. GROUP - FEES | 5,000 | 1,000 | 0 | 4,000 |
| SCHWAB - INVESTMENT MGMT. FEES | 13,783 | 13,783 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAX | 97 | 97 |